TY - JOUR T1 - Dr. Balevic,<em> et al</em>, reply JF - The Journal of Rheumatology JO - J Rheumatol DO - 10.3899/jrheum.200681 SP - jrheum.200681 AU - Stephen J. Balevic AU - Christoph P. Hornik AU - Thomas P. Green AU - Megan E. Clowse AU - Daniel Gonzalez AU - Anil R. Maharaj AU - Laura E. Schanberg AU - Amanda M. Eudy AU - Geeta K. Swamy AU - Brenna L. Hughes AU - Michael Cohen-Wolkowiez Y1 - 2020/05/25 UR - http://www.jrheum.org/content/early/2020/06/09/jrheum.200681.abstract N2 - We read with great interest the very thoughtful commentary by Joob and Wiwanitkit1. We agree with the authors that, despite conflicting clinical data to date, it is possible that hydroxychloroquine (HCQ) may have a protective effect in the setting of the coronavirus disease 2019 (COVID‑19). ER -